| dbo:abstract |
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University. (en) AM-2201 ist eine synthetisch hergestellte chemische Verbindung, die zu den Indol-Derivaten und Ketonen zählt. AM-2201 wirkt als synthetisches Cannabinoid auf die Rezeptoren des Endocannabinoid-Systems und entfaltet dort seine Wirkung. Die AM-Serie von Substanzen mit Cannabinoid-Wirkung wurden sämtlich von Alexandros Makriyannis an der Northeastern University erstmals hergestellt. Chemisch hat es eine starke Ähnlichkeit zu JWH-018. Es wird häufig als Rauschmittel gebraucht, da es etwa 30–40 mal potenter als Tetrahydrocannabinol ist. Schon Dosierungen von 250–500 µg zeigen Wirkung. (de) AM-2201、または1-(5-フルオロペンチル)-3-(1-ナフトイル)インドールは、に対する強力だが非選択的な完全作動薬として作用するデザイナードラッグである。のひとつとして、ノースイースタン大学のによって発見された。 (ja) AM-2201 – organiczny związek chemiczny, substancja psychoaktywna z grupy syntetycznych kannabinoidów. Działa jako silny, lecz nieselektywny agonista receptorów kannabinoidowych o Ki 1,0 nM do receptora CB1 oraz 2,6 nM do receptora CB2. Został po raz pierwszy zsyntetyzowany i opatentowany przez grupę , profesora w Bostonie. (pl) |
| dbo:casNumber |
335161-24-5 |
| dbo:fdaUniiCode |
TBJ0966F1O |
| dbo:pubchem |
53393997 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/AM-2201.svg?width=300 |
| dbo:wikiPageID |
30232690 (xsd:integer) |
| dbo:wikiPageLength |
5900 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1111446047 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Cannabinoid_receptor dbr:Bradycardia dbr:Designer_drug dbr:Pentane dbr:Cannabinoid_receptor_2_(macrophage) dbc:Designer_drugs dbc:Organofluorides dbr:Convulsions dbr:SDB-005 dbr:Alexandros_Makriyannis dbr:Full_agonist dbr:NM-2201 dbr:MAM-2201 dbr:Functional_analog_(chemistry) dbc:Naphthoylindoles dbr:Dissociation_constant dbr:List_of_AM_cannabinoids dbr:AM-1235 dbr:AM-2232 dbr:AM-2233 dbr:AM-694 dbr:Alkane dbr:Northeastern_University dbr:List_of_Schedule_I_drugs_(US) dbc:CB1_receptor_agonists dbc:CB2_receptor_agonists dbr:JWH-018 dbc:AM_cannabinoids dbr:THJ-018 dbr:THJ-2201 dbr:Metabolism dbr:MEPIRAPIM dbr:Cannabinoid_receptor_1 dbr:Recreational_drug dbr:Dealkylation |
| dbp:c |
24 (xsd:integer) |
| dbp:casNumber |
335161 (xsd:integer) |
| dbp:chemspiderid |
24751884 (xsd:integer) |
| dbp:f |
1 (xsd:integer) |
| dbp:h |
22 (xsd:integer) |
| dbp:iupacName |
1 (xsd:integer) |
| dbp:legalCa |
Schedule II (en) |
| dbp:legalDe |
Anlage II (en) |
| dbp:legalNz |
Temporary Class (en) |
| dbp:legalUk |
Class B (en) |
| dbp:legalUs |
Schedule I (en) |
| dbp:n |
1 (xsd:integer) |
| dbp:o |
1 (xsd:integer) |
| dbp:pubchem |
53393997 (xsd:integer) |
| dbp:smiles |
O=CC3=CC=CC4=C3C=CC=C4 (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
ALQFAGFPQCBPED-UHFFFAOYSA-N (en) |
| dbp:unii |
TBJ0966F1O (en) |
| dbp:verifiedfields |
changed (en) |
| dbp:verifiedrevid |
451565418 (xsd:integer) |
| dbp:watchedfields |
changed (en) |
| dbp:width |
180 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Cannabinoidergics dbt:Cannabinoids dbt:Citation_needed dbt:Drugbox dbt:Or dbt:See_also dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Stdinchicite |
| dcterms:subject |
dbc:Designer_drugs dbc:Organofluorides dbc:Naphthoylindoles dbc:CB1_receptor_agonists dbc:CB2_receptor_agonists dbc:AM_cannabinoids |
| gold:hypernym |
dbr:Drug |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAromaticKetones yago:WikicatMolecularFormulas yago:WikicatNaphthalenes yago:Abbreviation107091587 yago:Abstraction100002137 yago:Chemical114806838 yago:Communication100033020 yago:Compound114818238 yago:Form106290637 yago:Formula106816935 yago:Hydrocarbon114911057 yago:Ketone114926294 yago:LanguageUnit106284225 yago:Material114580897 yago:Matter100020827 yago:Message106598915 yago:MolecularFormula106817173 yago:Naphthalene114958564 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 yago:WikicatKetones yago:Word106286395 dbo:Drug yago:Statement106722453 yago:Substance100019613 yago:WikicatAbbreviations |
| rdfs:comment |
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University. (en) AM-2201 ist eine synthetisch hergestellte chemische Verbindung, die zu den Indol-Derivaten und Ketonen zählt. AM-2201 wirkt als synthetisches Cannabinoid auf die Rezeptoren des Endocannabinoid-Systems und entfaltet dort seine Wirkung. Die AM-Serie von Substanzen mit Cannabinoid-Wirkung wurden sämtlich von Alexandros Makriyannis an der Northeastern University erstmals hergestellt. Chemisch hat es eine starke Ähnlichkeit zu JWH-018. Es wird häufig als Rauschmittel gebraucht, da es etwa 30–40 mal potenter als Tetrahydrocannabinol ist. Schon Dosierungen von 250–500 µg zeigen Wirkung. (de) AM-2201、または1-(5-フルオロペンチル)-3-(1-ナフトイル)インドールは、に対する強力だが非選択的な完全作動薬として作用するデザイナードラッグである。のひとつとして、ノースイースタン大学のによって発見された。 (ja) AM-2201 – organiczny związek chemiczny, substancja psychoaktywna z grupy syntetycznych kannabinoidów. Działa jako silny, lecz nieselektywny agonista receptorów kannabinoidowych o Ki 1,0 nM do receptora CB1 oraz 2,6 nM do receptora CB2. Został po raz pierwszy zsyntetyzowany i opatentowany przez grupę , profesora w Bostonie. (pl) |
| rdfs:label |
AM-2201 (de) AM-2201 (en) AM-2201 (ja) AM-2201 (pl) |
| rdfs:seeAlso |
dbr:JWH-018 |
| owl:sameAs |
freebase:AM-2201 yago-res:AM-2201 wikidata:AM-2201 dbpedia-de:AM-2201 dbpedia-ja:AM-2201 dbpedia-pl:AM-2201 dbpedia-sh:AM-2201 dbpedia-sr:AM-2201 https://global.dbpedia.org/id/4Jn9Q |
| prov:wasDerivedFrom |
wikipedia-en:AM-2201?oldid=1111446047&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/AM-2201.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:AM-2201 |
| is dbo:wikiPageRedirects of |
dbr:C24H22FNO dbr:5F-NE-PIMO dbr:AM4_(cannabinoid) |
| is dbo:wikiPageWikiLink of |
dbr:List_of_designer_drugs dbr:Mepirapim dbr:Liebermann_reagent dbr:List_of_miscellaneous_designer_cannabinoids dbr:List_of_psychedelic_drugs dbr:Synthetic_cannabinoids dbr:SDB-005 dbr:STS-135_(drug) dbr:NNE1 dbr:MAM-2201 dbr:MN-18 dbr:BIM-018 dbr:5F-AMB dbr:5F-JWH-398 dbr:C24H22FNO dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:List_of_AM_cannabinoids dbr:5F-NNE1 dbr:5F-PB-22 dbr:5F-PCN dbr:AM-1220 dbr:AM-1235 dbr:AM-694 dbr:5-HT1A_receptor dbr:EAM-2201 dbr:FDU-NNE1 dbr:FDU-PB-22 dbr:FUBIMINA dbr:PB-22 dbr:List_of_Schedule_I_drugs_(US) dbr:Recreational_drug_use dbr:AM4 dbr:JWH-018 dbr:JWH-250 dbr:THJ-018 dbr:THJ-2201 dbr:CYP2C9 dbr:Cannabinoid dbr:Cannabinoid_receptor_type_1 dbr:XLR-11 dbr:FUB-PB-22 dbr:5F-NE-PIMO dbr:Temporary_class_drug dbr:AM4_(cannabinoid) |
| is foaf:primaryTopic of |
wikipedia-en:AM-2201 |
